Hyaluronidase was first used in human antituberculosis vaccination in 1950 (Salhioli, 1933) .
From the very first it was possible to see that the addition of hyaluronidase increases remarkably the vaccinating activity of killed tubercle bacilli injected intradermally. Also it was confirmed that their diffusion offered an interesting field of study not only of vaccinating antigens consisting of microbic bodies or of organized structures, but also of extractive antigens, of immune sera and of antibiotic drugs (Salvioli, 1933 The vaccinial focus had a slower and much longer evolution than that following vaccination without the addition of hyaluronidase. As soon as allergy has developed there is a phenomenon of recidivation which may lead to the formation of small superficial eschars and moderate secretion, especially in older individuals. The scar is mostly smooth or linear, and may even be absent.
Allergy appears after three or four months (Fig. 1) . The foregoing facts allow us to speculate on the mechanism of anti-tuberculosis and other vaccination, and on the constitution of various immunization phenomena, light on which may be obtained through a controlled use of the diffusing factor.
